Search Results - "Anand, Lovkesh"
-
1
Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: An open‐label randomized controlled trial
Published in Journal of gastroenterology and hepatology (01-07-2021)“…Background and Aim Sepsis is an important determinant of the outcome of acute‐on‐chronic liver failure (ACLF) patients. Omega‐3 fatty acids (FAs) are known to…”
Get full text
Journal Article -
2
Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy
Published in Hepatology (Baltimore, Md.) (01-08-2019)“…Autoimmune hepatitis (AIH) is considered less common in the Asia Pacific region. Due to this, AIH flare as a cause of acute on chronic liver failure (ACLF) is…”
Get full text
Journal Article -
3
Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis
Published in Liver international (01-01-2019)“…Background Exogenous growth factor‐mobilized bone marrow (BM) stem cells have shown a differential response in the management of decompensated cirrhosis (DC)…”
Get full text
Journal Article -
4
A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism
Published in Liver international (01-04-2019)“…Background Parkinsonism like features can be seen in cirrhotics, possibly related to alterations in brain dopamine metabolism, transport and receptor integrity…”
Get full text
Journal Article -
5
Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India
Published in Hepatology communications (01-06-2022)“…Tinospora cordifolia (Giloy) is an herbal supplement commonly used in the Indian alternative medicine system Ayurveda. This herb has been promoted to the…”
Get full text
Journal Article -
6
Guillain-Barré syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review
Published in Intractable & Rare Diseases Research (01-02-2019)“…Hepatitis E is a serious public health problem in developing countries. Most of the patients with Hepatitis E virus (HEV) infection present with typical acute…”
Get full text
Journal Article -
7
SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure
Published in Digestive diseases and sciences (01-02-2018)“…Background and Aims Almost 10% of bleeding episodes are refractory to combination of vasoactive agent and endotherapy, and are associated with a mortality up…”
Get full text
Journal Article -
8
Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
Published in Clinical and molecular hepatology (01-06-2019)“…The aim of this study was to study the efficacy and safety of zolpidem for sleep disturbances in patients with cirrhosis. Fifty-two Child-Turcotte-Pugh (CTP)…”
Get full text
Journal Article -
9
Suboptimal Level of Bone‐Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy
Published in Hepatology communications (01-09-2018)“…Bone loss is common in advanced cirrhosis, although the precise mechanisms underlying bone loss in cirrhosis are unknown. We studied the profile and…”
Get full text
Journal Article -
10
Sonoclot Signature Analysis in Patients with Liver Disease and Its Correlation with Conventional Coagulation Studies
Published in Advances in hematology (2013)“…Introduction. Liver disease patients have complex hemostatic defects leading to a delicate, unstable balance between bleeding and thrombosis. Conventional…”
Get full text
Journal Article -
11
-
12
-
13
-
14
-
15
-
16
-
17
Combination of Granulocyte Colony-Stimulating Factor and Erythropoietin Improves Outcomes of Patients With Decompensated Cirrhosis
Published in Gastroenterology (New York, N.Y. 1943) (01-06-2015)“…Background & Aims Patients with decompensated cirrhosis have significantly reduced survival without liver transplantation. Granulocyte colony-stimulating…”
Get full text
Journal Article -
18
Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months
Published in Digestive diseases and sciences (01-03-2023)“…Background and Study Aims Weight reduction is the mainstay treatment for Nonalcoholic steatohepatitis (NASH). intragastric balloon (IGB) placement has proven…”
Get full text
Journal Article -
19
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Published in Hepatology international (01-09-2020)“…Background and aims COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with…”
Get full text
Journal Article -
20
Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study
Published in Liver international (01-11-2017)“…Background Alterations in body composition (BC) as loss of fat and muscle mass (sarcopenia) are associated with poor outcome in alcoholic cirrhosis (ALC)…”
Get full text
Journal Article